What is the COPD Analytic Accelerator?

Actionable insight to improve quality of life and care across the continuum for patients with COPD.

The COPD Analytic Accelerator supports a disciplined, data-driven approach to the evaluation and management of patients with COPD, helping to drive and sustain improvement in clinical and financial outcomes. Typical implementations focus on confirmatory testing (spirometry), treatment optimization, care management and coordination, and exacerbation management—areas where getting it right is especially meaningful to improve quality and cost.

COPD Analytic Accelerator Background

COPD is the third leading cause of death in the U.S. and it presents a considerable burden to society, diminishing patients’ quality of life and raising healthcare costs. Organizations choose to focus on COPD to address these impacts and because they see:

  • Significant variation in care, despite well established guidelines. Unwarranted practice variation typically signals an improvement opportunity.
  • Opportunity to affect care across the continuum. Well documented initiatives have been shown to reduce hospital admissions, lower costs, and improve quality of life.

COPD Analytic Accelerator Benefits and Features

Gain an at-a-glance view of quality of care and its impact.

he application visualizes outcome and process metrics in an easy-to-consume, one-page summary. This allows you to see trends as they develop—and take timely action to address issues.

Access actionable insight for every patient.

The application presents reports showing each patient’s severity and risk so you can provide appropriate interventions to prevent readmission.

Understand the resources required to provide care for every patient with COPD.

Depending on the availability of data, the application can bring in data from both ambulatory and hospital settings, in and out of network, to help surface the cost of care, utilization of services, and frequency of exacerbations.

Start faster with meaningful, scalable clinical definitions.

The cohorts, definitions, and process measures that come with the accelerator are clinically relevant, standard, and meaningful across domains, ready for customization or adoption in your organization. Organizations are able to look at patients’ demographic information, medication history, and clinical features—not just administrative codes (e.g., ICD, CPT codes)—to precisely identify cohorts of patients with COPD and at risk for COPD.

Identify improvement opportunities and focus on what matters most.

Outcome metrics typically include mortality, readmission, ED and hospital utilization rate, LOS, and cost per case. Typical process metrics include documentation of spirometry and compliance with care protocols related to medication optimization and care transitions. The result? Your team understands the priorities and can help solve problems that stand in the way of improvement.